Latest News
Researchers from the University of Oregon (OR, USA) suggest that noninvasive EEG readings could present as easily detectable biomarkers to help diagnose and improve treatment for Parkinson’s and other motor disorders.
Enrollment in all ongoing Depatux-M studies has been halted for newly diagnosed glioblastoma due to lack of survival benefit.
Researchers have reported that individuals undergoing CAR T-cell therapy for blood cancers are at risk of neurological side effects; categorizing and understanding these side effects could be important in future diagnosis and treatment.
Journal Articles
Jenny Straiton explores the miniature world of organoids and discusses how these small models are making big changes in the world of neurological research.
In this commentary from Future Neurology, the authors overview and compare cerebral organoids and other 3D aggregated cell cultures.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Regenerative stroke therapies: an interview with Steven Cramer
Stroke recovery: could the microbiome be a new therapeutic option?
The obesity paradox: could excess body fat improve stroke survival rates?
CNS/PNS/SNS
New technology generates synthetic speech using brain activity
Cerebral organoids: scientists grow ‘mini-brains’ that can contract muscle
Cognitive/neurodegenerative disorders
Alzheimer’s symptoms alleviated by antibiotic treatment in male mice, study reveals
The vermiform appendix as a contributor to Parkinson’s disease: an interview with Viviane Labrie
WHO releases first-ever guideline for reducing the risk of dementia
Demyelinating disease
Multiple sclerosis: determining the dynamic nature of oligodendrocyte regeneration
Biomarker discovery and development in multiple sclerosis: where are we now?
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Development and pediatrics
Brain organoids: defining maturity, addressing the challenges and exploring future directions
Autism development may be linked to disruption of placental neurosteroids
Cerebral organoids: scientists grow ‘mini-brains’ that can contract muscle
Epilepsy and seizure
Cannabidiol may reduce seizures in children with Dravet syndrome
Epilepsy charity calls for regulation of flashing imagery online
Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
Genetics
Ask the Experts: Gene therapies in neurological diseases (Part II: challenges and future outlooks)
Ask the Experts: Gene therapies in neurological diseases (Part I: development, design and delivery)
SfN18: The potential of gene therapy in neurological disorders
Headache
Why are migraines more common in women? New sex-specific insights revealed
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Alzheimer’s drug development halted following toxic reaction: industry news round-up
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
Could a bacterial polysaccharide suppress fatal brain inflammation?
Link between Alzheimer’s disease and periodontal bacteria gains traction
Injury/trauma
Tau biomarker linked to chronic traumatic encephalopathy in former athletes
New technology generates synthetic speech using brain activity
Abnormal tau protein detected by experimental PET scan in brains of former NFL players
Movement disorders
Could a noninvasive biomarker for Parkinson’s disease lie in EEG data?
The vermiform appendix as a contributor to Parkinson’s disease: an interview with Viviane Labrie
Novel therapeutic targets for Parkinson’s disease: an interview with Patrik Brundin
Neuro-ophthalmology
Gene therapy breakthrough allows mice to regain sight
Could an eye scan detect signs of Alzheimer's disease?
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Brain ‘fingerprinting’: a whole-system perspective into psychiatric conditions
Cerebral organoids: scientists grow ‘mini-brains’ that can contract muscle
Could targeting 'extinction neurons' help treat anxiety and PTSD?
Oncology/tumor
Depatux-M fails to meet primary endpoint in late-stage trial for newly diagnosed glioblastoma
CAR T-cell therapy: what are the neurological side effects?
SurVaxM for newly diagnosed glioblastoma: an interview with Manmeet Ahluwalia
Pain
Why are migraines more common in women? New sex-specific insights revealed
Could neuropathic pain be treated by modulation of immune cells?
New smartphone application could detect first signs of opioid overdose
Sleep
Tau accumulation in the brain may be linked to sleep apnea
Sleep deprivation: can you catch-up on the weekend?
Night owls vs morning larks: are there differences in brain function?
